Antihistamines and antiemetics
DXM combinations with substances in this group.
PHI is a provisional hazard rating for a combination with DXM on a 0–10 scale.
- No PHI rating
Why is there no PHI rating?
Full explanation from the review
Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44]. Datura and Atropa belladonna are excluded because variable alkaloid concentrations undermine the known-exposure assumption [35]. Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31]. Their concerns are discussed in Sections 5 and 8.
Find combinations by mechanism
Here the combinations are grouped by interaction mechanism.
Serotonin-related (1)
Cardiovascular and thermal
This category is not marked in the review
Sedation and respiration (6)
- DXM + Diphenhydramine, dimenhydrinate, doxylaminePHI 4 to 6
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Cyclizine, meclizine, hydroxyzinePHI 3 to 5
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Loratadine, desloratadine, cetirizinePHI 1 to 3 ? uncertain contribution
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
Metabolism (1)
- DXM + Diphenhydramine, dimenhydrinate, doxylaminePHI 4 to 6 ? uncertain contribution
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
NMDA
This category is not marked in the review
Antimuscarinic (5)
- DXM + Diphenhydramine, dimenhydrinate, doxylaminePHI 4 to 6
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Cyclizine, meclizine, hydroxyzinePHI 3 to 5
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
Seizure-related concern
This category is not marked in the review
Other discussed pathways
This category is not marked in the review